Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?
7/19/2011
More...
|
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study
1/28/2011
More...
|
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study
12/30/2010
More...
|
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial
12/13/2010
More...
|
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study
12/7/2010
More...
|
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study
11/11/2010
More...
|
American Association for Study of Liver Diseases: Early Study Shows HCV Vaccine Works, Scripps Clinic Study
11/3/2010
More...
|
American Association for Study of Liver Diseases: Rapid Response for Once-Daily Protease Inhibitor, University of North Carolina Study
11/3/2010
More...
|
American Academy of Ophthalmology: Glaucoma Drug Passes Early Clinical Test
10/21/2010
More...
|
Ceregene, Inc. Initiates a New Controlled Phase 2b Trial of Cere-120 for Parkinson's Disease
10/19/2010
More...
|
American Society for Bone and Mineral Research: Novel Drug Promising in Osteoporosis, University of Erlangen Study Reveals
10/19/2010
More...
|
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression
10/19/2010
More...
|
ESMO: New Agent Active in Advanced Ovarian Cancer, Dana-Farber Cancer Institute Study
10/15/2010
More...
|
ESMO: No Help from PARP Inhibitor in Ovarian Cancer, Royal Marsden Hospital Study
10/14/2010
More...
|
New Targeted Therapy Adds Benefit to Erlotinib in Some Patients with Advanced Lung Cancer, Sarah Cannon Research Institute Study
10/11/2010
More...
|
Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea
5/20/2013
More...
|
Cempra Pharmaceuticals, Inc. Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results From Patients With Community Acquired Bacterial Pneumonia (CABP)
5/20/2013
More...
|
Synageva BioPharma (GEVA)'s Sebelipase Alfa Receives Breakthrough Therapy Designation for Early Onset LAL Deficiency From the FDA
5/20/2013
More...
|
Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
5/20/2013
More...
|
Sangamo BioSciences, Inc. (SGMO) Presents New Data From In Vivo Protein Replacement Platform for Development of ZFP Therapeutics® for Monogenic Diseases
5/20/2013
More...
|
Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes
5/20/2013
More...
|
Safety Results From Auris Medical AG's Clinical Development of AM-101 Presented at International Conference
5/17/2013
More...
|
Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting
5/17/2013
More...
|
Gradalis Inc. Release: FANG™ Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer
5/16/2013
More...
|
Verona Pharma to Present Clinical and Pre-Clinical Data Highlighting the Significant Bronchodilator Activity of Novel Dual PDE3/4 Inhibitor RPL554 at Upcoming American Thoracic Society International Conference
5/16/2013
More...
|
New Data to be Presented at the 2013 American Society of Clinical Oncology Annual Meeting Show Active Biotech AB (BTPC)'s Commitment to Oncology Research
5/16/2013
More...
|
GENFIT Corp. (ALGFT) Release: GFT505 Reduces the Risk of Cardiovascular Events Through Its Action on Remnant Cholesterol
5/15/2013
More...
|
Plandai Biotechnology, Inc. (PLPL.OB) Announces Positive Anti-Malaria Test Results Using Phytofare™ Extract
5/15/2013
More...
|
Sangamo BioSciences, Inc. (SGMO) Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-T
5/15/2013
More...
|
Inovio Pharmaceuticals (INO) DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
5/14/2013
More...
|